Common Contracts
3 similar Investors’ Rights Agreement contracts by Auspex Pharmaceuticals, Inc., Zoosk, Inc
ZOOSK, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT December 21, 2011Investors’ Rights Agreement • February 24th, 2014 • Zoosk, Inc • Services-computer programming, data processing, etc. • California
This Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of December 21, 2011, by and among Zoosk, Inc., a Delaware corporation (the “Company”), and the holders of Series A Preferred Stock of the Company, the holders of Series B Preferred Stock of the Company, the holders of Series C Preferred Stock of the Company, the holders of Series D Preferred Stock of the Company, the purchasers of Series E Preferred Stock of the Company, and certain holders of warrants to purchase Preferred Stock of the Company, as collectively listed on Exhibit A to this Agreement (individually, an “Investor” and collectively, the “Investors”).
AUSPEX PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT December 20, 2013Investors’ Rights Agreement • December 20th, 2013 • Auspex Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of December 20, 2013, by and among Auspex Pharmaceuticals, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A-1, Series A-2, Series A-3, Series A-4 and Series A-5 Preferred Stock set forth on Exhibit A attached hereto (the “Series A Holders”), the holders of Series B Preferred Stock set forth on Exhibit A attached hereto (the “Series B Holders”), the holders of Series C Preferred Stock set forth on Exhibit A attached hereto (the “Series C Holders”), the holders of Series D Preferred Stock set forth on Exhibit A attached hereto (the “Series D Holders”) and the holders of Series E Preferred Stock set forth on Exhibit A attached hereto (the “Series E Holders,” and together with the Series A Holders, the Series B Holders, the Series C Holders and the Series D Holders, the “Investors”).
AUSPEX PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT October 31, 2012Investors’ Rights Agreement • November 21st, 2013 • Auspex Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of October 31, 2012, by and among Auspex Pharmaceuticals, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A-1, Series A-2, Series A-3, Series A-4 and Series A-5 Preferred Stock set forth on Exhibit A attached hereto (the “Series A Holders”), the holders of Series B Preferred Stock set forth on Exhibit A attached hereto (the “Series B Holders”), the holders of Series C Preferred Stock set forth on Exhibit A attached hereto (the “Series C Holders”) and the holders of Series D Preferred Stock set forth on Exhibit A attached hereto (the “Series D Holders,” and together with the Series A Holders, the Series B Holders and the Series C Holders, the “Investors”).
